Endothelial cells – the cells that line blood vessels – grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found.
“Fashioning the Boundaries of Free Speech,” an exhibit that’s part of Cornell’s Freedom of Expression theme year, will be on display in the Human Ecology Building and the Herbert F. Johnson Museum of Art from Sept. 28 to Jan. 15, 2024.
Teams from eLab, Cornell’s student accelerator, and Cornell Tech’s Runway Startups program will pitch their ideas to the West Coast Cornell community at Cornell Silicon Valley Presents: Student Startup Showcase March 30 at the Autodesk Gallery in San Francisco.
The 2023 VCNG Continuation of Service Award was presented to Jennifer Ross, an Executive MBA Metro NY candidate in the Samuel Curtis Johnson Graduate School of Management at the Cornell SC Johnson College of Business.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Today, the New York City Council is likely to pass a package of legislation that will set minimum pay and improve working conditions for app-based delivery workers. Patricia Campos-Medina, executive director of the Worker Institute at Cornell University’s School of Industrial and Labor Relations, says the protections expected to be approved today are needed, but much more must be done.
A Cornell Tech clinic has created a new approach to helping survivors of domestic abuse stop assailants from hacking into their devices and social media to surveil and harass them.
Disruption of the circadian clocks that keep the body and its cells entrained to the 24-hour day-night cycle plays a critical role in weight gain, according to a pair of studies by Weill Cornell Medicine investigators.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
